Identification and characterization of functional antioxidant response elements in the promoter of the aldo-keto reductase AKR1B10 gene

被引:15
|
作者
Nishinaka, Toru [1 ]
Miura, Takeshi [2 ]
Shimizu, Kahori [1 ]
Terada, Tomoyuki [1 ]
机构
[1] Osaka Ohtani Univ, Fac Pharm, Lab Biochem, 3-11-1 Nishikiori Kita, Osaka 5848540, Japan
[2] Mukogawa Womens Univ, Sch Pharm & Pharmaceut Sci, Pharmaceut Educ Support Ctr, 11-68 Koshien,9-Bancho, Nishinomiya, Hyogo 6638179, Japan
关键词
Aldo-keto reductase; Nrf2; AP-1; Antioxidant response element; Transcription; Lung; H23; A549; c-Jun; OLIGONUCLEOTIDE MICROARRAY; HEPATOCELLULAR-CARCINOMA; PANCREATIC-CARCINOMA; OXIDATIVE STRESS; CANCER CELLS; MEMBER B10; TRANSCRIPTION; EXPRESSION; PATHWAY; GROWTH;
D O I
10.1016/j.cbi.2017.02.008
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
AKR1B10 is a human-type aldo-keto reductase. The up-regulation of AKR1B10 has been associated with various cancers including non-small cell lung carcinoma, viral and bacterial infections, and skin diseases. However, the mechanisms underlying AKR1B10 gene regulation are not fully understood. We previously indicated the involvement of the transcription factor Nrf2 in AKR1B10 gene regulation. There are at least five potential Nrf2-responsive consensus sequences, so-called antioxidant response elements (AREs), and several ARE-like sequences in the 5'-flanking region up to -3282 bp of the AKR1B10 gene. In the present study, we attempted to identify functional AREs by luciferase reporter analyses using various mutants for each ARE. And we found that only those between -530 and -520 bp (ARE-A), which is the closest location to the translation start site, were functional among the five ARE consensus sites examined. Furthermore, ARE-A functioned co-operatively with the neighboring AP-1 site. Since the AP-1 site resembles ARE, the tandem arrangement of these two elements may be essential for augmented responsiveness to Nrf2 and plays an important role in AKR1B10 gene regulation by various Nrf2-mediating stimuli. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:160 / 166
页数:7
相关论文
共 50 条
  • [31] In Search for Inhibitors of Human Aldo-Keto Reductase 1B10 (AKR1B10) as Novel Agents to Fight Cancer and Chemoresistance: Current State-of-the-Art and Prospects
    Maccari, Rosanna
    Ottana, Rosaria
    JOURNAL OF MEDICINAL CHEMISTRY, 2025, 68 (02) : 860 - 885
  • [32] Aldo Keto Reductases AKR1B1 and AKR1B10 in Cancer: Molecular Mechanisms and Signaling Networks
    Banerjee, Sreeparna
    CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE, 2021, 1347 : 65 - 82
  • [33] Gene expression and promoter analysis of a novel tomato aldo-keto reductase in response to environmental stresses
    Suekawa, Marina
    Fujikawa, Yukichi
    Inada, Shuhei
    Murano, Asako
    Esaka, Muneharu
    JOURNAL OF PLANT PHYSIOLOGY, 2016, 200 : 35 - 44
  • [34] GAIN OF EXPRESSION OF ALDO-KETO REDUCTASE FAMILY 1 B10 (AKR1B10) PROTEIN IN PANCREATIC ADENOCARCINOMA: AN EARLY EVENT INVOLVED IN PANCREATIC CARCINOGENESIS AND A POTENTIAL THERAPEUTIC TARGET
    Matkowskyj, K. A.
    Chung, Y. T.
    Liao, J.
    Li, H.
    Bai, H.
    Zhang, W.
    Yang, G.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2011, 59 (04) : 726 - 727
  • [35] Substrate specificity of a mouse aldo-keto reductase (AKR1C12)
    Endo, Satoshi
    Matsumoto, Kengo
    Matsunaga, Toshiyuki
    Ishikura, Shuhei
    Tajima, Kazuo
    El-Kabbani, Ossama
    Hara, Akira
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2006, 29 (12) : 2488 - 2492
  • [36] In-silico identification and ex-vivo validation in humans of distinct oncogenic potential of aldo-keto reductase AKR1B10 in hepatocellular carcinoma from alcohol induced liver injury
    Waters, Michael
    Sukriti, Sukriti
    Sharma, Chhagan
    Negi, Preeti
    Patel, Bhaumik
    Fuchs, Michael
    Sarin, Shiv Kumar
    Puri, Puneet
    JOURNAL OF HEPATOLOGY, 2023, 78 : S149 - S150
  • [37] Characterization of a rat NADPH-dependent aldo-keto reductase (AKR1B13) induced by oxidative stress
    Endo, Satoshi
    Matsunaga, Toshiyuki
    Mamiya, Hiroaki
    Hara, Akira
    Kitade, Yukio
    Tajima, Kazuo
    El-Kabbani, Ossama
    CHEMICO-BIOLOGICAL INTERACTIONS, 2009, 178 (1-3) : 151 - 157
  • [38] Aldo-keto reductase (AKR) 1C3 as an androgen receptor coactivator
    Narayanan, Ramesh
    Yepuru, Muralimohan
    Wu, Zhongzhi
    Barrett, Christina
    Kim, Juhyun
    Penning, Trevor M.
    Steiner, Mitchell S.
    Miller, Duane D.
    Dalton, James T.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (06)
  • [39] Aldo-Keto Reductase (AKR) 1C3 inhibitors: a patent review
    Penning, Trevor M.
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2017, 27 (12) : 1329 - 1340
  • [40] Pharmacogenetics of aldo-keto reductase 1C (AKR1C) enzymes
    Alshogran, Osama Y.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2017, 13 (10) : 1063 - 1073